Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probuphine in Patients With Opioid Dependence
NCT00447564Phase 3Completed
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- Oct 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine implant in opioid use disorder (OUD), sponsored by Titan Pharmaceuticals, Inc.. Started Oct 2006; status: completed.
02
Drugs
buprenorphine implant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00447564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447564.